Clinical Trial Update: Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 3 study of marimastat in patients with stage III non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Marimastat (marimastat)

Snippet

Sponsor: ILEX Oncology Services, Incorporated | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED